Manorama Industries Approves Subsidiary Capital Infusions and Board Changes
Manorama Industries Ltd · Others (Uncategorized) · 05 Sept 2026, 1:52 am
Manorama Industries Approves Subsidiary Capital Infusions and Board Changes Manorama Industries' board approved capital infusions totaling up to ₹75 Cr across six wholly owned subsidiaries: Manorama Savanna Ghana (up to ₹20 Cr), Manorama Burkina SARL (up to ₹15 Cr), Manorama Latin America (up to ₹15 Cr), Manorama Savanna Nigeria (up to ₹10 Cr), Manorama Savannah Agro Chad (up to ₹10 Cr), and Manorama Mena Trading UAE (up to ₹5 Cr) to support working capital and global expansion. Additionally, Dr. Rohini Tiwari was appointed as Non-Executive Independent Director for five years effective 4th Sep'26, while Mudit Kumar Singh completed his directorship tenure.
Original exchange filing (PDF)
More announcements from Manorama Industries Ltd
- Transcript of Q2 & H1 FY27 Earnings Conference Call held on Friday, November 13, 2026. · 17 Nov 2026
- Intimation of Investor meet scheduled to be held on Wednesday, November 18, 2026. · 13 Nov 2026
- Intimation of Audio recording of the Q2 & H1 FY27 Earnings Conference Call with Analyst /Investors held on Friday, November 13, 2026 · 13 Nov 2026
- Investor Presentation · 13 Nov 2026
- Press Release · 13 Nov 2026
- Monitoring Agency Report · 13 Nov 2026
- Statement of Deviation and Variation · 13 Nov 2026
- Outcome of Board Meeting dated November 12, 2026 · 13 Nov 2026
